Overview

A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, 4-sequence, 2-period, double-blind, placebo controlled study in male and female subjects with an American Psychiatric Association Diagnostic and Statistical Manual DSM-IV-TR diagnosis of cocaine abuse.
Phase:
Phase 2
Details
Lead Sponsor:
Indivior Inc.
Treatments:
Cocaine